An open label, randomized, phase II study of AS1404 in combination with carboplatin and paclitaxel in patients with platinum-sensitive recurrent ovarian epithelial cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Carboplatin; Paclitaxel; Vadimezan
- Indications Ovarian cancer
- Focus Therapeutic Use
- 23 Sep 2007 Interim results presented at ECCO 2007.
- 11 Nov 2005 New trial record.